Intrahepatic Cholangiocarcinoma — Trials

Intrahepatic Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 88
Recruiting: 53
Ph III recruiting: 2
Growth YoY: +23.8%
Industry share: 9%
Top sponsor: Fudan University
Termination share: 47.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05681949	Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards(ADBoard)	unknown	N/A	1,200	Charite University, Berlin, GermanyOTHER	1	Aug 24, 2023	clinicaltrials
NCT05247996	TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma	unknown	N/A	98	The Central Hospital of Lishui CityOTHER	0	Feb 21, 2022